Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 61-80 of 203 (Search time: 0.006 seconds).

Issue DateTitleContributor(s)TypeCat.
612016Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancerMichiels, Stefan; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; BUYSE, Marc; Piccart, M.Journal ContributionA1
622016Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group TrialTimmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
632016Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszJournal ContributionA1
642016Neoadjuvant as Future for Drug Development in Breast Cancer-LetterBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA1
652016The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical TrialsPeron, Julien; Roy, Pascal; Ozenne, Brice; Roche, Laurent; BUYSE, MarcJournal ContributionA1
662016Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'Saad, E. D.; BUYSE, MarcJournal ContributionA1
672016Adaptive Randomization of Neratinib in Early Breast CancerBUYSE, Marc; Saad, E.; BURZYKOWSKI, TomaszJournal ContributionA1
682016An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal InferenceALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
692016Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agentsSaad, E. D.; BUYSE, MarcJournal ContributionA1
702016Neratinib after trastuzumab in patients with HER2-positive breast cancer ReplyChan, Arlene; BUYSE, Marc; Yao, BinJournal ContributionA1
712015Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid LeukemiaSchlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionM
722015Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancerCiani, Oriana; BUYSE, Marc; Garside, Ruth; Peters, Jaime; Saad, Everardo D.; Stein, Ken; Taylor, Rod S.Journal ContributionA1
732015On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
742015Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkersZhao, Lili; Feng, Dai; Neelon, Brian; BUYSE, MarcJournal ContributionA1
752015Biomarker‑based surrogate endpointsBUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, ArielBook SectionB2
762014Implementation Issues in Adaptive Design TrialsDanielson, Linda; Carlier, Jerome; BURZYKOWSKI, Tomasz; BUYSE, MarcBook SectionB2
772014Data Sharing, Year 1 - Access to Data from Industry-Sponsored Clinical TrialsStrom, Brian L.; BUYSE, Marc; Hughes, John; Knoppers, Bartha M.Journal ContributionA2
782014Linear mixed-effects models for central statistical monitoring of multicenter clinical trialsDesmet, L.; Venet, D.; Doffagne, E.; Timmermans, C.; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
792013Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used?MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
802013Professor Maurice Staquet, MD, MS (1930-2013) In MemoriamDuez, Nicole; Eeckhoudt, Dominique; Kirkpatrick, Anne; Solbu, Gabriel; Suciu, Stefan; SYLVESTER, Richard; Van Glabbeke, Martine; BUYSE, Marc; Dalesio, Otilia; Renard, Josette; Rotmensz, NicoleJournal ContributionM